Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-067732
Filing Date
2024-08-12
Accepted
2024-08-12 16:51:13
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210893-10q_citius.htm   iXBRL 10-Q 588544
2 AT THE MARKET OFFERING AGREEMENT ea021089301ex1-1_citius.htm EX-1.1 214665
3 LEGEL OPINION ea021089301ex5-1_citius.htm EX-5.1 5779
4 CERTIFICATION ea021089301ex31-1_citius.htm EX-31.1 9740
5 CERTIFICATION ea021089301ex31-2_citius.htm EX-31.2 10903
6 CERTIFICATION ea021089301ex32-1_citius.htm EX-32.1 4642
  Complete submission text file 0001213900-24-067732.txt   4285944

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ctxr-20240630.xsd EX-101.SCH 40793
8 XBRL CALCULATION FILE ctxr-20240630_cal.xml EX-101.CAL 31516
9 XBRL DEFINITION FILE ctxr-20240630_def.xml EX-101.DEF 192225
10 XBRL LABEL FILE ctxr-20240630_lab.xml EX-101.LAB 350259
11 XBRL PRESENTATION FILE ctxr-20240630_pre.xml EX-101.PRE 185814
61 EXTRACTED XBRL INSTANCE DOCUMENT ea0210893-10q_citius_htm.xml XML 377687
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 241197644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)